CFDE Data Portal | Search CACNA2D3-AS1

	Label	Description
	CACNA2D3-AS1 associations Collection (Entity type)	Associations for CACNA2D3-AS1_associations
	CACNA2D3-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CACNA2D3-AS1 Gene (Entity type)	ENSG00000243715 - CACNA2D3 antisense RNA 1
	GSE195568 palbociclib 2 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226285 3 V 0 GLUTATHIONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE128240 0 V 1 CYCLOPHOSPHAMIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE212330 azacitidine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 11 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 6 V 5 ETOPOSIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 paclitaxel 2 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

CACNA2D3-AS1 associations

Associations for CACNA2D3-AS1_associations

CACNA2D3-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

CACNA2D3-AS1

ENSG00000243715 - CACNA2D3 antisense RNA 1

GSE195568 palbociclib 2 v 10 human up

A Gene Set from LINCS

GSE226285 3 V 0 GLUTATHIONE HUMAN UP

A Gene Set from LINCS

GSE128240 0 V 1 CYCLOPHOSPHAMIDE MOUSE UP

A Gene Set from LINCS

GSE212330 azacitidine 1 v 0 human dn

A Gene Set from LINCS

GSE108464 AZ-628 11 v 12 human up

A Gene Set from LINCS

GSE120612 6 V 5 ETOPOSIDE HUMAN DN

A Gene Set from LINCS

GSE172016 paclitaxel 2 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.